Yasmeen Rahimi
Stock Analyst
(2.94)
# 498
Out of 4,648 analysts
77
Total ratings
37.25%
Success rate
2.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $1.33 | +426.32% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $5.81 | +347.50% | 2 | Oct 30, 2024 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $48 → $51 | $34.48 | +47.91% | 3 | Oct 11, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $18.03 | +105.21% | 2 | Sep 23, 2024 | |
| ZURA Zura Bio | Maintains: Overweight | $26 | $4.37 | +494.97% | 2 | Sep 19, 2024 | |
| SLRN Acelyrin | Maintains: Overweight | $68 → $20 | $5.82 | +243.64% | 2 | Aug 14, 2024 | |
| IMUX Immunic | Reiterates: Overweight | $28 | $1.20 | +2,233.33% | 3 | Jul 16, 2024 | |
| CRNX Crinetics Pharmaceuticals | Maintains: Overweight | $97 | $56.82 | +70.71% | 4 | Jul 2, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $270 | $70.02 | +285.60% | 3 | Jul 1, 2024 | |
| TECX Tectonic Therapeutic | Initiates: Overweight | $76 | $41.87 | +81.51% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $6.79 | +268.19% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $10.80 | +177.78% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $5.32 | +125.56% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $38.15 | -5.64% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.48 | +1,775.39% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $60.13 | +199.35% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.89 | +1,592.43% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $331.32 | +1.41% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $3.70 | +332.43% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $19.94 | +301.20% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $56.14 | +65.66% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $39.74 | +134.02% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $26.90 | +141.64% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $29.42 | +93.75% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.42 | +1,136.16% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $46.76 | -25.15% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $22 | $1.25 | +1,660.00% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $11.11 | +683.08% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $94 | $16.46 | +471.08% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $9.48 | +1,745.99% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $1.21 | +729.88% | 1 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $51.48 | +39.86% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $14.49 | +86.34% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $9.29 | +104.52% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $2.15 | +2,225.58% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $2.41 | +1,559.75% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.73 | +2,382.76% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $0.60 | +3,372.80% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $17.82 | +332.10% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $4.42 | +488.90% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $40.45 | +90.36% | 1 | Jul 31, 2020 |
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $1.33
Upside: +426.32%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $5.81
Upside: +347.50%
Edgewise Therapeutics
Oct 11, 2024
Maintains: Overweight
Price Target: $48 → $51
Current: $34.48
Upside: +47.91%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $18.03
Upside: +105.21%
Zura Bio
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $4.37
Upside: +494.97%
Acelyrin
Aug 14, 2024
Maintains: Overweight
Price Target: $68 → $20
Current: $5.82
Upside: +243.64%
Immunic
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.20
Upside: +2,233.33%
Crinetics Pharmaceuticals
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $56.82
Upside: +70.71%
Praxis Precision Medicines
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $70.02
Upside: +285.60%
Tectonic Therapeutic
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $41.87
Upside: +81.51%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $6.79
Upside: +268.19%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $10.80
Upside: +177.78%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $5.32
Upside: +125.56%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $38.15
Upside: -5.64%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.48
Upside: +1,775.39%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $60.13
Upside: +199.35%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.89
Upside: +1,592.43%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $331.32
Upside: +1.41%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $3.70
Upside: +332.43%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $19.94
Upside: +301.20%
Feb 5, 2024
Initiates: Overweight
Price Target: $93
Current: $56.14
Upside: +65.66%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $39.74
Upside: +134.02%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $26.90
Upside: +141.64%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $29.42
Upside: +93.75%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.42
Upside: +1,136.16%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $46.76
Upside: -25.15%
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $1.25
Upside: +1,660.00%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $11.11
Upside: +683.08%
Jan 27, 2023
Initiates: Overweight
Price Target: $94
Current: $16.46
Upside: +471.08%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $9.48
Upside: +1,745.99%
Aug 12, 2022
Initiates: Overweight
Price Target: $10
Current: $1.21
Upside: +729.88%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $51.48
Upside: +39.86%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $14.49
Upside: +86.34%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $9.29
Upside: +104.52%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $2.15
Upside: +2,225.58%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $2.41
Upside: +1,559.75%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.73
Upside: +2,382.76%
Aug 26, 2020
Initiates: Overweight
Price Target: $21
Current: $0.60
Upside: +3,372.80%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $17.82
Upside: +332.10%
Aug 26, 2020
Initiates: Overweight
Price Target: $26
Current: $4.42
Upside: +488.90%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $40.45
Upside: +90.36%